Machine Learning Approach to Sonographic Assessment of Tumor Volumes for Response Assessment in Patients With Pancreas or Gastrointestinal Adenocarcinoma: A Pilot Study
Sponsor: Memorial Sloan Kettering Cancer Center
Trial Details
| Condition | Pancreas Cancer, Gastrointestinal Adenocarcinoma |
| Intervention | ultrasound |
| Phase | NA |
| Status | Active |
| Participants | 19 |
| Est. Completion | 6 Apr 2027 |
| Last Updated | 27 Apr 2026 |
Primary Outcome
measurement differences between ultrasound tumor volumes
Eligibility Criteria
Inclusion Criteria
Inclusion Criteria: * Male and female patients, 18 years of age or older * Confirmed diagnosis of PDAC or GI tract adenocarcinoma metastatic to liver * Scheduled for imaging with contrast enhanced CT Exclusion Criteria: * Inability to tolerate intravenous contrast medium * All liver metastases ≤ 10 mm in maximal diameter on the contrast enhanced CT used for comparison to the planned research ultrasound * Multiple confluent liver metastases or tumor burden \> 50% of the liver as estimated by a radiologist
Trial Sites
Countries
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service